跳至主要内容
临床试验/EUCTR2009-013294-18-HU
EUCTR2009-013294-18-HU进行中(未招募)不适用

Magnesiumsulfate in the prevention of post-ERCP pancreatitis – a prospective randomized, placebocontrolled multicenter study

niversity of Szeged, First Department of Internal Medicine0 个研究点目标入组 802 人开始时间: 2014年1月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
802

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult (= 18 years of age) patients (male and female) with a medical indication for a diagnostic or therapeutic
  • endoscopic retrograde cholangiopancreatography (ERCP).
  • Written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known allergy or intolerance to one of the medicaments utilized in the study or their ingredients
  • Participation in another clinical study during the previous four weeks
  • Pregnancy and breast feeding
  • Acute pancreatitis
  • Renal insufficiency = stadium 4 (K/DOQI)
  • Hyperthyreoidism
  • Symptomatic Bradycardia <35 bpm
  • Atrioventricular block > 1° or other cardial conduction defects
  • Myasthenia gravis
  • Liver cirrhosis Child C
  • Any apparent coagulopathy
  • Kidney stone diathesis (calcium-magnesium-ammonium-phosphate stones)
  • Mental impairment, addicitve or other disorders leading to the patients inability to understand the scope and
  • possible consequences of a participation in the clinical trial
  • Magnesium medication within 14 days before the procedure
  • Inability to give informed consent

研究者

发起方
niversity of Szeged, First Department of Internal Medicine

相似试验

Magnesiumsulfate in the prevention of post-ERCP... | 临床试验